Positional genomic analysis identifies the β2-adrenergic receptor gene as a susceptibility locus for human hypertension

Circulation

Volumn 101, Issue 25, 2000, Pages 2877-2882

  Bray, Molly S ^a,b   Krushkal, Julia ^a   Li, Li ^a   Ferrell, Robert ^c   Kardia, Sharon ^d   Sing, Charles F ^e   Turner, Stephen T ^f   Boerwinkle, Eric ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f MAYO CLINIC   (United States)

Author keywords

Blood pressure; Genetics; Linkage (genetics); Polymorphism (genetics)

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; GLUTATHIONE PEROXIDASE;

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME 5; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; DNA SEQUENCE; FAMILY; FEMALE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PEDIGREE; POINT MUTATION; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES;

EID: 0034720848     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.25.2877     Document Type: Article

References (29)

1. JNC. Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
2. Chobanian A, Alexander R. Exacerbation of atherosclerosis by hypertension: potential mechanisms and clinical implications. Arch Intern Med. 1996;156:1952-1956.
3. Alexander R. Theodore Cooper memorial lecture: hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 1995; 25:155-161.
4. Wilson P, D'Agostino R, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
5. Williams R, Hunt S, Hopkins P, et al. Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah. Am J Hypertens. 1993;6:319S-327S.
6. Rice T, Vogler G, Perusse L, et al. Cardiovascular risk factors in a French Canadian population: resolution of genetic and familial environmental effects on blood pressure using twins, adoptees, and extensive information on environmental correlates. Genet Epidemiol. 1989;6:571-588.
7. Krushkal J, Xiong M, Ferrell R, et al. Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet. 1998;7:1379-1383.
8. Krushkal J, Ferrell R, Mockrin S, et al. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation. 1999;99:1407-1410.
9. Turner ST, Michels VV. Sodium-lithium countertransport and hypertension in Rochester, Minnesota. Hypertension. 1991;18:183-190.
10. Turner S, Sing C. Erythrocyte sodium transport and the probability of having hypertension. J Hypertens. 1996;14:829-837.
11. Nickerson DA, Tobe VO, Taylor SL. PolyPHRED: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 1997;25:2745-2751.
12. Nickerson D, Kaiser R, Lappin S, et al. Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc Natl Acad Sci U S A. 1990;87:8923-8927.
13. Spielman R, Ewens W. A sibship test of linkage in the presence of association: the sib transmission/disequilibrium test. Am J Hum Genet. 1998;62:450-458.
14. Boerwinkle E, Chakraborty R, Sing C. The use of measured genotype information in the analysis of quantitative phenotype in man. Ann Hum Genet. 1986;50:181-194.
15. George V, Elston R. Testing the association between polymorphic markers and quantitative traits in pedigrees. Genet Epidemiol. 1987;4: 193-201.
16. SAGE: Statistical Analysis for Genetic Epidemiology. New Orleans, La: Department of Biometry and Genetics, LSU Medical Center; 1994.
17. Ferrell R, Levinson K, Esman J, et al. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum Mol Genet. 1998;7: 2073-2078.
18. Weiss K. Genetic Variation and Human Disease: Principles and Evolutionary Approaches. New York, NY: Cambridge University Press; 1993.
19. Chruscinski A, Rohrer D, Schauble E, et al. Targeted disruption of the β2 adrenergic receptor gene. J Biol Chem. 1999;274:16694-16700.
20. Green S, Turki J, Innis M, et al. Amino-terminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 1994;33:9414-9419.
21. Kotanko P, Binder A, Tasker J, et al. Essential hypertension in African Caribbean associates with a variant of the β2-adrenoceptor. Hypertension. 1997;30:773-776.
22. Gratze G, Fortin J, Labugger R, et al. β-2 adrenergic receptor variant affect resting blood pressure and agonist-induced vasodilation in young adult caucasians. Hypertension. 1999;33:1425-1430.
23. Turki J, Pak H, Green S, et al. Polymorphisms of the β2 adrenergic receptor in nocturnal and non-nocturnal asthma: evidence that Gly 16 correlates with the nocturnal phenotype. J Clin Invest. 1995;95:1635-41.
24. Martinez F, Graves P, Baldini M, et al. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest. 1997;100: 3184-3188.
25. Hall I, Wheatley A, Wilding P, et al. Association of the Glu27 b2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet. 1995;345:1213-1214.
26. Mori Y, Kim-Motoyama H, Ito Y, et al. The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun. 1999;258: 138-140.
27. Meirhaeghe A, Helbecque N, Cottel D, et al. Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet. 1999;353:896.
28. Large V, Hellstrom L, Reynisdottir S, et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest. 1997;100: 3005-3013.
29. Dorn GN, Tepe N, Lorenz J, et al. Low- and high-level transgenic expression of β2-adrenergic receptors differentially affect cardiac hypertrophy and function in Gaq-overexpressing mice. Proc Natl Acad Sci U S A. 1999;96:6400-6405.